Home
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

600 public trials 70 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Recruiting

ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants

NCT06787144

Conditions: Bone Marrow Diseases, CML (Chronic Myelogenous Leukemia), Chronic Disease, +13 more
Locations: Akita University Hospital Akita, Japan

Aiiku Hospital Sapporo, Hokkaido, Japan

The University of Osaka Hospital Suita-shi, Osaka, Japan

Tokyo Medical University Hospital Shinjuku-ku, Tokyo, Japan

View Trial Details

Recruiting

ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

NCT06680661

Conditions: Acute Lymphatic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +28 more
Locations: University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Recruiting

Study of Olverembatinib (HQP1351) in Patients With CP-CML

NCT06423911

Conditions: Bone Marrow Diseases, CML, CML, Chronic Phase, +14 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBP

NCT06390306

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: Peking university people's hospital Beijing, Beijing Municipality, China

Beijing Lu Daopei Hospital Beijing, China

Chuiyangliu hospital affiliated to tsinghua university Beijing, China

Sichuan Provincial People's Hospital Chengdu, China

View all 15 locations

View Trial Details

Recruiting

Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial

NCT06355583

Conditions: Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukaemia, Acute Myeloid Leukemia, +27 more
Locations: University Hospitals Birmingham NHS Foundation Trust Birmingham, England, United Kingdom

Leeds Teaching Hospital NHS Trust Leeds, England, United Kingdom

University College London Hospitals NHS Trust London, England, United Kingdom

Kings College NHS Foundation Trust London, England, United Kingdom

View Trial Details

Recruiting

Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia

NCT05130138

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: CHU de Saint-Etienne Saint-Etienne, France

View Trial Details

Recruiting

Efficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid Leukemia

NCT05282108

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +13 more
Locations: National Cancer Institute (NCI) Cairo, Egypt

Ain Shams University Hospital Cairo, Egypt

Nasser Institute Cairo, Egypt

Tanta Oncology Center Tanta, Egypt

View Trial Details

Recruiting

TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia

NCT06088888

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations: The University of Texas MD Anderson Cancer Center Houston, Texas, United States

Fred Hutchinson Cancer Center Seattle, Washington, United States

View Trial Details

Recruiting

TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients

NCT06453902

Conditions: Accelerated Phase CML, Bone Marrow Diseases, Chronic Disease, +13 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Condition Vasoregulation Function Endothelium in Patients With CML Getting TKI II Generation Bosutinib

NCT05682924

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukaemia, +11 more
Locations: National Medical Research Centre for Hematology Moscow, Russia

Samara State Medical University Samara, Russia

View Trial Details

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Related conditions